2022
DOI: 10.1016/j.drudis.2022.04.020
|View full text |Cite
|
Sign up to set email alerts
|

Pharmaceutical strategies for the treatment of bacterial biofilms in chronic wounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 30 publications
(14 citation statements)
references
References 85 publications
1
13
0
Order By: Relevance
“…(iii) Biofilm maturation where microcolonies progressively increase, recruiting more microbial cells, together with the deposition of organic and inorganic solutes. (iv) Detachment of cells that occurs when some cells detach from the biofilm individually or in clusters to colonize new niches [ 16 , 41 ].…”
Section: Infected Woundsmentioning
confidence: 99%
See 1 more Smart Citation
“…(iii) Biofilm maturation where microcolonies progressively increase, recruiting more microbial cells, together with the deposition of organic and inorganic solutes. (iv) Detachment of cells that occurs when some cells detach from the biofilm individually or in clusters to colonize new niches [ 16 , 41 ].…”
Section: Infected Woundsmentioning
confidence: 99%
“…Additionally, the infected wound can be considered a chronic inflammatory state that can increase the mortality rate [ 15 ]. Chronic wounds, such as diabetic foot and pressure ulcers, have a greater propensity for the formation of biofilms of pathogenic bacteria since the environment constituted by necrotic tissue and debris allows the attachment of these microorganisms [ 16 ]. In view of this, it is mandatory to understand the cellular basis of wound pathology in order to develop therapeutically viable and cost-effective treatments.…”
Section: Introduction To Wound Healingmentioning
confidence: 99%
“…Wounds or skin injuries can provide an excellent habitat for biofilm formation, which can impair the host immune system, exacerbate the patient's condition, and retard the wound closure rate. 57 Therefore, strategies to target the microbial recalcitrant biofilms are essential. In this regard, CYNFs with promising antibiofilm activity could be used as a smart wound dressing material to achieve better clinical outcomes.…”
Section: Storage Stability Analysismentioning
confidence: 99%
“…This helps fight antibiotic resistance. Some antimicrobial nanotherapeutics have the potential to stop biofilms from forming and kill pathogens that live inside cells [ 54 ]. Prominently, nanoparticle surface chemistry is helpful in functionalizing more than one therapeutic agent to target specifically one kind of cell.…”
Section: Nanomedicine-based Advancement In Sepsismentioning
confidence: 99%